-transparent.png){kind=logo}
Isosorbide dinitrate, which releases nitric oxide in vivo, and prostaglandin E1 synergised in reducing platelet deposition and increasing platelet survival time in patients with peripheral vascular disease.
Related Publications
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
January 1983,
The Mount Sinai journal of medicine, New York,
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
October 1976,
Lancet (London, England),
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
October 1985,
Japanese circulation journal,
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
December 1982,
The Journal of the Medical Society of New Jersey,
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
June 1997,
Journal of anesthesia,
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
November 2002,
Prostaglandins, leukotrienes, and essential fatty acids,
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
April 1982,
Clinical physiology (Oxford, England),
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
October 1985,
Fortschritte der Medizin,
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
November 1981,
British medical journal (Clinical research ed.),
H Sinzinger, and
P Fitscha, and
J O'Grady, and
F Rauscha, and
W Rogatti, and
J R Vane
January 1983,
Zeitschrift fur Kardiologie,
